AT-101, a small molecule inhibitor of anti-apoptotic Bcl-2 family members, activates the SAPK/JNK pathway and enhances radiation-induced apoptosis
Shuraila F. Zerp(The Netherlands Cancer Institute), Marcel Verheij(The Netherlands Cancer Institute)
Cited by 58
Related Papers
Targeting anti-apoptotic Bcl-2 by AT-101 to increase radiation efficacy: data from in vitro and clinical pharmacokinetic studies in head and neck cancer
|Radiation Oncology|2015|49
Fas/CD95 down-regulation in lymphoma cells through acquired alkyllysophospholipid resistance: partial role of associated sphingomyelin deficiency
|Biochemical Journal|2009|19
Enhancing radiation response by a second-generation TRAIL receptor agonist using a new in vitro organoid model system
|Clinical and Translational Radiation Oncology|2020|9